Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Aoshima

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Acta Neuropathologica|March 6, 2023
A point mutation in GPI-attachment signal peptide accelerates the development of prion diseaseAtsushi Kobayashi, Tetsuya Hirata, Taishi Shimazaki, et al.
Veterinary Medicine and Science|July 24, 2023
Diverse genome-wide DNA methylation alterations in canine hepatocellular tumoursYu Asari, Jumpei Yamazaki, Oo Thandar, et al.
Cancer Research|November 7, 2019
Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase InhibitionMolly Gale, Yao Li, Jian Cao, et al.
Science Translational Medicine|February 2, 2022
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppressionMeiling Zhang, Zongzhi Z Liu, Keisuke Aoshima, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Acta Neuropathologica|March 6, 2023
A point mutation in GPI-attachment signal peptide accelerates the development of prion diseaseAtsushi Kobayashi, Tetsuya Hirata, Taishi Shimazaki, et al.
Veterinary Medicine and Science|July 24, 2023
Diverse genome-wide DNA methylation alterations in canine hepatocellular tumoursYu Asari, Jumpei Yamazaki, Oo Thandar, et al.
Cancer Research|November 7, 2019
Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase InhibitionMolly Gale, Yao Li, Jian Cao, et al.
Science Translational Medicine|February 2, 2022
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppressionMeiling Zhang, Zongzhi Z Liu, Keisuke Aoshima, et al.
Pageof 6